Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
The results from a head-to-head comparison of two different neurokinin-1 receptor antagonists for the prevention of chemotherapy induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Longest median overall survival in a phase III melanoma study reported to date and the first report of melanoma-specific survival
Efficacy was evaluated in AMPECT study in patients with locally advanced unresectable or metastatic malignant PEComa
Withdrawal concerns application to use Cervarix in individuals from the age of 9 years for the prevention of head and neck cancers
The results from a randomised, phase III DAWNA-1 study with a new, orally administered, selective CDK4/6 inhibitor
Results from the first prospective study showing that patients with HER2-amplified metastatic colorectal cancer identified by ctDNA genotyping benefit from dual-HER2 blockade similarly to patients identified by conventional tissue analysis
It is intended for the treatment of patients with advanced NSCLC with KRAS G12C mutation who have progressed after at least one prior line of systemic therapy
Evidence for efficacy is based on the results from the KEYNOTE-564 study
Generating high-quality evidence from registry-based studies
Evidence for efficacy is based on the results from the ASCEMBL and CABL001X2101 studies
It is indicated for treatment of adult patients with advanced NSCLC with activating EGFR Exon 20 insertion mutations, after failure of platinum-based therapy
PET may have utility in predicting long term benefit and help guide discontinuation of therapy
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
